News
0
Bristol-Myers Squibb has agreed to sell off Celgene’s psoriasis treatment Otezla, to appease antitrust regulators.
0
Pfizer’s Talzenna (talazoparib) has secured approval in Europe from the European Commission, the drugmaker has confirmed, as a monotherapy for the...
0
Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil.
0
Vertex has announced that the FDA has chosen to expand the existing authorisation on its cystic fibrosis (CF) therapy Symdeko.
Features
Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit appears as an...
Featured Appointment
The Institute of Cancer Research (ICR) has said GlaxoSmithKline’s Dr Adrian Cottrell will join as the institute’s new Chief Information Officer....
Service Company News
Featured Event
25/09/2019 - 26/09/2019 -
London,
@Pharmafocus
